BOARD AND COMMITEE MEMBERSHIPS
2015 - 2017
Chief of Staff, St. Vincent’s Medical Center – Southside
2013 - 2017
Board of Directors, St. Vincent’s Healthcare
2012 - 2014
Chairman, Department of Internal Medicine, St. Vincent's Medical Center - Southside
2011 - Present
Lab Director, Southpoint, Southside and Southside Central Laboratory, Cancer Specialists, LLC
2009 - 2014
Chief, Division of Hematology & Oncology, St. Vincent’s Medical Center – Southside
2018 - Present
Chief, Division of Hematology & Oncology, St. Vincent’s Medical Center – Southside
2016 - Present
Quality Patient Safety Committee, St. Vincent’s Medical Center – Southside
2014 - Present
New Product Decision Team, St. Vincent’s Medical Center – Southside
2013 - Present
Medical Staff Executive Committee, Specialty Hospital
2012 - Present
Chairman, Medical Staff Executive Committee, St. Vincent’s Medical Center – Southside
2011 - Present
Performance Improvement Committee, Department of Medicine, Memorial Hospital
2011 - 2013
Peer Review Committee, Specialty Hospital
2011 - 2013
Peer Review Committee, Specialty Hospital
2013 - 2018
Executive Committee, Specialty Hospital
2008 - 2014
Credentials Committee, St. Vincent’s Medical Center – Southside
2009 - Present
EMR Committee, St. Vincent’s Medical Center – Southside
HONORS AND AWARDS
2014
Service of the Poor Award, St. Vincent’s Medical Center
2009
Wisdom Award, St. Vincent’s Medical Center
2001
Foundations of Clinical Medicine Teaching Award
1994
Beta Beta Beta, Biological Honor Society
RESEARCH (Principal Investigator Responsibilities)
NCT03371979
A Phase 1/2 study of Pegzilarginase (AEB1102-Ca-Argl-PEG) in combination with pembrolizumab in the treatment of patients with extensive disease (ED) small cell lung cancer (SCLC). Phase I/II, Interventional
NCT03400098
Expanded Access Program for Tegsedi (inotersen) (ISIS 420915) in Patients with Hereditary Transthyretin Amyloidosis (hATTR). Expanded Access
NCT02993731
A Phase III Study of BBI-608 Plus Nab-Paclitaxel with Gemcitabine in Adult Patients with Metastatic Pancreatic Adenocarcinoma. Phase III, Interventional
NCT02923921
A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compare with FOLFOX Alone as Second-line Therapy in Patients with Metastatic Pancreatic Cancer that has Progressed During or Following a First-Line Gemcitabine Containing Regimen. Phase III, Interventional
NCT02538666
A Randomized, Multicenter, Double-Blind, Phase 3 Study of Nivolumab, Nivolumab in Combination with Ipilimumab, or Placebo as Maintenance Therapy in Subjects with Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) after Completion of Platinum-base First Line Chemotherapy. Phase III, Interventional
NCT02200757
A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects with Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy. Phase II, Interventional
NCT01956812
An International, Multi-Center, Double-Blind, Randomized, Phase III Trial of 90Y-Clivatuzumab Tetraxetan plus Low-Dose Gemcitabine Versus Placebo plus Low-Dose Gemcitabine in Patients with Metastatic (Stage IV) Pancreatic Adenocarcinoma Who Received at Least Two Prior Treatments. Phase III, Interventional
NCT01831726
Modular Phase II Study to Link Targeted Therapy to Patients with Pathway Activated Tumors: Module 2 - Dovitinib for Patients with Tumor Pathway Activations Inhibited by Dovotonib Including Tumors with Mutations of Translocations of FGFR, PDGFR, VEGF, CKIT, FLT3, CSFR1, TRK and RET. Phase II, Interventional
NCT03500549
Study to Evaluate the Efficacy and Safety of APL-2 in Patients with PNH
NCT01831726
Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid Tumors
NCT03531255
APL-2 Long Term Safety and Efficacy Extension Study
NCT01831726
Stool Collection Sub-Study of Exact Sciences Protocol 2018-01: "Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid Tumors
PUBLICATIONS
Lung Cancer
"ALDH1A1 and ALDH3A1 Expression in Lung Cancers: Correlation with Histologic Type and Potential Precursors"
Journal of Clinical Oncology
"Retrospective Review of State III Non-Small Lung Cancer Patients Treated With Carboplatin/Paclitaxel Plus Radiotherapy Followed by Docetaxel"
Oncology Handbook 2nd and 3rd Editions
"NSCLC, ScLC, Mesothelioma, Renal Cell Carcinoma, and Head & Neck Cancers"
Journal of Parasitology
"Inhibitory Effect of Chlorpromazine on Nematode Eggs and Larvae"
Journal of Parasitology
"Inhibitory Effect of ChlorproEnhanced Ability of Third-Stage Larvae of Haemonchus contortus to Withstand Drug Exposure after Chemically Induced Exsheathment"mazine on Nematode Eggs and Larvae"
Bios, Volume 68
"Effects of Ivermectin on Eggs and First-stage Larvae of Nematodes"